Appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Zheng, Huiyuan ^a   Corkern, Michele ^a   Stoyanova, Irina ^a   Patterson, Laurel M ^a   Tian, Rui ^a   Berthoud, Hans Rudolf ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Cocaine amphetamine related transcript; Elicited feeding; Food reward; GABA agonist; Neuropeptide Y; Nucleus accumbens; Proopiomelanocortin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ANOREXIGENIC AGENT; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; MELANIN CONCENTRATING HORMONE; MUSCIMOL; NEUROPEPTIDE Y; OREXIN A; OXYTOCIN; PROOPIOMELANOCORTIN; PROTEIN C FOS; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CARRIER PROTEIN; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; MELANIN; MELANIN-CONCENTRATING HORMONE; NERVE PROTEIN; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; THALAMUS MIDLINE NUCLEUS; ANIMAL; ANTERIOR HYPOTHALAMUS; CYTOLOGY; DRUG EFFECT; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APPETITE REGULATION; ARCUATE NUCLEUS; CARRIER PROTEINS; FEEDING BEHAVIOR; GABA AGONISTS; GENE EXPRESSION REGULATION; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MELANINS; MUSCIMOL; NERVE TISSUE PROTEINS; NEURONS; NEUROPEPTIDE Y; NEUROPEPTIDES; NUCLEUS ACCUMBENS; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY HORMONES; PRO-OPIOMELANOCORTIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038521147     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00781.2002     Document Type: Article

References (63)

1. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, Barsh GS, and Watson SJ. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and pro-opiomelanocortin in brain. J Neurosci 19: RC26, 1999.
2. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20: 1-25, 1996.
3. Bittencourt JC and Elias CF. Diencephalic origins of melanin-concentrating hormone immunoreactive projections to medial septum/diagonal band complex and spinal cord using two retrograde fluorescent tracers. Ann NY Acad Sci 680: 462-465, 1993.
4. Bittencourt JC, Frigo L, Rissman RA, Casatti CA, Nahon JL, and Bauer JA. The distribution of melanin-concentrating hormone in the monkey brain (Cebus apella). Brain Res 804: 140-143, 1998.
5. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, and Sawchenko PE. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319: 218-245, 1992.
6. Briski KP and Sylvester PW. Hypothalamic orexin-A-immunpositive neurons express Fos in response to central glucopenia. Neuroreport 12: 531-534, 2001.
7. Broberger C, De Lecea L, Sutcliffe JG, and Hokfelt T. Hypocretin/orexin- and melanin- concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402: 460-474, 1998.
8. Burlet S, Tyler CJ, and Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22: 2862-2872, 2002.
9. Butler AA and Cone RD. The melanocortin receptors: lessons from knockout models. Neuropeptides 36: 77-84, 2002.
10. Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JR, Wilson S, and Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50: 105-112, 2001.
11. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451, 1999.
12. Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, Beuckmann CT, Chemelli RM, Sakurai T, Yanagisawa M, Saper CB, and Scammell TE. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21: RC168, 2001.
13. Colantuoni C, Rada P, McCarthy J, Patten C, Avena NM, Chadeayne A, and Hoebel BG. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 10: 478-488, 2002.
14. Colantuoni C, Schwenker J, McCarthy J, Rada P, Ladenheim B, Cadet JL, Schwartz GJ, Moran TH, and Hoebel BG. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12: 3549-3552, 2001.
15. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, and Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484, 2001.
16. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, and Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96: 748-753, 1999.
17. Dube MG, Kalra SP, and Kalra PS. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 842: 473-477, 1999.
18. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, and Bloom SR. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160: R7-12, 1999.
19. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, and Elmquist JK. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21: 1375-1385, 1998.
20. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, and Elmquist JK. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442-459, 1998.
21. Espana RA, Plahn S, and Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res 943: 224-236, 2002.
22. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, and Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 21: 1656-1662, 2001.
23. Fadel J, Bubser M, and Deutch AY. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 22: 6742-6746, 2002.
24. Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA, and Shiromani PJ. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 21: 7273-7283, 2001.
25. Groenewegen HJ and Russchen FT. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J Comp Neurol 223: 347-367, 1984.
26. Guan JL, Saotome T, Wang QP, Funahashi H, Hori T, Tanaka S, and Shioda S. Orexinergic innervation of POMC-containing neurons in the rat arcuate nucleus. Neuroreport 12: 547-551, 2001.
27. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC, and Seeley RJ. Long-term orexigenic effects of AgRP-(83 - 132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 279: R47-R52, 2000.
28. Harrison TA, Chen CT, Dun NJ, and Chang JK. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci Lett 273: 17-20., 1999.
29. Haynes AC, Chapman H, Taylor C, Moore GB, Cawthorne MA, Tadayyon M, Clapham JC, and Arch JR. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul Pept 104: 153-159, 2002.
30. Hill JO and Peters JC. Environmental contributions to the obesity epidemic. Science 280: 1371-1374, 1998.
31. Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS, and van Den Pol AN. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415: 145-159, 1999.
32. Hwang LL, Chen CT, and Dun NJ. Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 537: 511-520, 2001.
33. Joseph SA, Pilcher WH, and Knigge KM. Anatomy of the corticotropin-releasing factor and opiomelanocortin systems of the brain. Fed Proc 44: 100-107, 1985.
34. Knigge KM, Joseph SA, and Nocton J. Topography of the ACTH-immunoreactive neurons in the basal hypothalamus of the rat brain. Brain Res 216: 333-341, 1981.
35. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393: 72-76, 1998.
36. Kyrkouli SE, Stanley BG, Seirafi RD, and Leibowitz SF. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 11: 995-1001, 1990.
37. Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkotou E, Elmquist J, Lowell B, Flier JS, and Maratos-Flier E. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107: 379-386, 2001.
38. Maldonado-Irizarry CS, Swanson CJ, and Kelley AE. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 15: 6779-6788, 1995.
39. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, and Palmiter RD. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21: 119-122, 1999.
40. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, and Trayhurn P. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8: 733-735, 1996.
41. Mogenson GJ, Jones DL, and Yim CY. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14: 69-97, 1980.
42. Mogenson GJ and Yang CR. The contribution of basal fore-brain to limbic-motor integration and the mediation of motivation to action. Adv Exp Med Biol 295: 267-290, 1991.
43. 2+ in orexin neurons of the rat lateral hypothalamus. Neurosci Lett 309:165-168, 2001.
44. Mystkowski P, Seeley RJ, Hahn TM, Baskin DG, Havel PJ, Matsumoto AM, Wilkinson CW, Peacock-Kinzig K, Blake KA, and Schwartz MW. Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss. J Neurosci 20: 8637-8642, 2000.
45. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, and Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 827: 243-260, 1999.
46. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, and Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015, 1998.
47. Rada PV and Hoebel BG. Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape decreases it. Brain Res 888: 60-65, 2001.
48. Reynolds SM and Berridge KC. Fear and feeding in the nucleus accumbens shell: rostrocaudal segregation of GABA-elicited defensive behavior versus eating behavior. J Neurosci 21:3261-3270, 2001.
49. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Upton N, Porter RA, Johns A, and Blundell JE. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13: 1444-1452, 2001.
50. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, and Bloom SR. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138: 351-355, 1997.
51. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, and Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20: 8620-8628, 2000.
52. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, and Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
53. Shimada M, Tritos NA, Lowell BB, Flier JS, and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670-674, 1998.
54. Stanley BG, Kyrkouli SE, Lampert S, and Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7: 1189-1192, 1986.
55. Stanley BG, Magdalin W, Seirafi A, Thomas WJ, and Leibowitz SF. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res 604: 304-317, 1993.
56. Stanley BG, Willett VL III, Donias HW, Ha LH, and Spears LC. The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating. Brain Res 630: 41-49, 1993.
57. Stratford TR and Kelley AE. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. J Neurosci 19:11040-11048, 1999.
58. Stratford TR and Kelley AE. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J Neurosci 17: 4434-4440, 1997.
59. Stratford TR, Kelley AE, and Simansky KJ. Blockade of GABAA receptors in the medial ventral pallidum elicits feeding in satiated rats. Brain Res 825: 199-203, 1999.
60. Sweet DC, Levine AS, Billington CJ, and Kotz CM. Feeding response to central orexins. Brain Res 821: 535-538, 1999.
61. Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, and Goto K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res 849: 248-252, 1999.
62. Zardetto-Smith AM, Moga MM, Magnuson DJ, and Gray TS. Lateral hypothalamic dynorphinergic efferents to the amygdala and brainstem in the rat. Peptides 9: 1121-1127, 1988.
63. Zheng H, Corkern MM, Crousillac SM, Patterson LM, Phifer CB, and Berthoud HR. Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP. Am J Physiol Regul Integr Comp Physiol 282: R1773-R1781, 2002.